-
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor Partial Agonism
STAMFORD, Conn., June 05, 2026 (GLOBE NEWSWIRE) — Oban BioPharma today announced that preclinical data for OBT-676, a
Lifestyle Content
Technology
-
Roadtrippers Launches $250,000 Premium Membership Giveaway to Celebrate America’s 250th Anniversary
-
Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
-
Enjoy the Best Tacos in Texas at the Second Annual Texas Monthly Taco Fest
-
Monotronic’s Long-Awaited ‘Turtle and the Hare’ by Ramsey Elkholy Set for Friday Release. Prepare to be Surprised!
-
Patterson-UTI Reports Drilling Activity for May 2026
Entertainment
-
Prime Biome Reviews (Report 2026) Mentioned in Growing Debate on Gut Health, Microbiome Balance, and Skin Wellness
-
Digital Erasure: Why Health and Longevity Platforms are Losing Their Domains to Automated Bots
-
Protecting Online Retail Infrastructure in Competitive and Litigious Markets
-
Infrastructure Matters: Domain Stability Emerging as a Critical Issue for Global File-Sharing Platforms
-
The Digital Printing Press: Why Journalists and Free Speech Platforms Are Moving to Trustname in 2026
Health
-
A look inside the growing Australian truffle tourism industry, where dogs sniff and schnapps follow
-
Don Franky Premium Reserve Coffee Company Builds a Community of Coffee Lovers One Freshly Roasted Cup at a Time From Dallas Texas
-
L’VOYAGE, Hong Kong-based Private Jet Charter, Reports 30% Rise in Private Jet Charter Activity Over Six Months
-
Why 62% of Americans lower their eco-values on vacation
-
Asia Odyssey Travel Expands 2026 and 2027 China Tours and Japan Tours With Ongoing Promo Discounts
